abstract |
The present invention provides a method for inhibiting uterine fibroid disease comprising administering to a woman in need of treatment an effective amount of a compound of formula In n wherein n R is hydrogen or methyl; n R 1 and R 2 each are methyl or ethy, or R 1 and R 2 together with the nitrogen atom to which they are attached represent a saturated heterocyclic group; and n X is bromo, chloro, fluoro, or hydrogen; or a pharmaceutically acceptable salt thereof. |